메뉴 건너뛰기




Volumn 110, Issue 3, 2015, Pages 368-377

Funding a smoking cessation program for crohn's disease: An economic evaluation

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; VARENICLINE; BENZAZEPINE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; NICOTINE GUM; NICOTINIC AGENT; QUINOXALINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

EID: 84924445959     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.300     Document Type: Article
Times cited : (26)

References (43)
  • 1
    • 84886783174 scopus 로고    scopus 로고
    • Risk of surgery for infl ammatory bowel diseases has decreased over time: A systematic review and metaanalysis of population-based studies
    • Frolkis AD , Dykeman J , Negron ME et al. Risk of surgery for infl ammatory bowel diseases has decreased over time: A systematic review and metaanalysis of population-based studies . Gastroenterology 2013 ; 145 : 996-1006
    • (2013) Gastroenterology , vol.145 , pp. 996-1006
    • Frolkis, A.D.1    Dykeman, J.2    Negron, M.E.3
  • 2
    • 83755219473 scopus 로고    scopus 로고
    • Increasing incidence and prevalence of the infl ammatory bowel diseases with time, based on systematic review
    • quiz e30
    • Molodecky NA , Soon IS , Rabi DM et al. Increasing incidence and prevalence of the infl ammatory bowel diseases with time, based on systematic review . Gastroenterology 2012 ; 142 : 46-54 e42; quiz e30
    • (2012) Gastroenterology , vol.142 , pp. 46-54e42
    • Molodecky, N.A.1    Soon, I.S.2    Rabi, D.M.3
  • 3
    • 56749105799 scopus 로고    scopus 로고
    • The eff ect of smoking aft er surgery for crohn's disease: A meta-analysis of observational studies
    • Reese GE , Nanidis T , Borysiewicz C et al. The eff ect of smoking aft er surgery for Crohn's disease: A meta-analysis of observational studies . Intl J Colorectal Dis 2008 ; 23 : 1213-21
    • (2008) Intl J Colorectal Dis , vol.23 , pp. 1213-1221
    • Reese, G.E.1    Nanidis, T.2    Borysiewicz, C.3
  • 4
    • 9144228789 scopus 로고    scopus 로고
    • Risk of early surgery for crohn's disease: Implications for early treatment strategies
    • Sands BE , Arsenault JE , Rosen MJ et al. Risk of early surgery for Crohn's disease: Implications for early treatment strategies . Am J Gastroenterol 2003 ; 98 : 2712-8
    • (2003) Am J Gastroenterol , vol.98 , pp. 2712-2718
    • Sands, B.E.1    Arsenault, J.E.2    Rosen, M.J.3
  • 5
    • 0035087887 scopus 로고    scopus 로고
    • Smoking cessation and the course of crohn's disease: An intervention study
    • Cosnes J , Beaugerie L , Carbonnel F et al. Smoking cessation and the course of Crohn's disease: An intervention study . Gastroenterology 2001 ; 120 : 1093-9
    • (2001) Gastroenterology , vol.120 , pp. 1093-1099
    • Cosnes, J.1    Beaugerie, L.2    Carbonnel, F.3
  • 6
    • 0024803939 scopus 로고
    • A meta-analysis of the role of smoking in infl ammatory bowel disease
    • Calkins BM . A meta-analysis of the role of smoking in infl ammatory bowel disease . Dig Dis Sci 1989 ; 34 : 1841-54
    • (1989) Dig Dis Sci , vol.34 , pp. 1841-1854
    • Calkins, B.M.1
  • 7
    • 84876229056 scopus 로고    scopus 로고
    • Environment and the infl ammatory bowel diseases
    • Frolkis A , Dieleman LA , Barkema H et al. Environment and the infl ammatory bowel diseases . Can J Gastroenterol 2013 ; 27 : E18-e24
    • (2013) Can J Gastroenterol , vol.27 , pp. e18-e24
    • Frolkis, A.1    Dieleman, L.A.2    Barkema, H.3
  • 8
    • 77953307288 scopus 로고    scopus 로고
    • Environmental risk factors for infl ammatory bowel disease
    • Molodecky NA , Kaplan GG . Environmental risk factors for infl ammatory bowel disease . Gastroenterol Hepatol (NY) 2010 ; 6 : 339-46
    • (2010) Gastroenterol Hepatol (NY , vol.6 , pp. 339-346
    • Molodecky, N.A.1    Kaplan, G.G.2
  • 9
    • 84873717324 scopus 로고    scopus 로고
    • High smoking cessation rate in crohn's disease patients aft er physician advice-The tabacrohn study
    • Nunes T , Etchevers MJ , Merino O et al. High smoking cessation rate in Crohn's disease patients aft er physician advice-The TABACROHN Study. J Crohns Colitis 2012 ; 7 : 202-7
    • (2012) J Crohns Colitis , vol.7 , pp. 202-207
    • Nunes, T.1    Etchevers, M.J.2    Merino, O.3
  • 10
    • 84924458322 scopus 로고    scopus 로고
    • High smoking cessation rate in crohns disease patients attending a multicenter anti-Tobacco program: The tabacrohn study
    • San Diego CA USA
    • Nunes T , Etchevers MJ , Merino O et al. High smoking cessation rate in Crohns disease patients attending a multicenter anti-Tobacco program: The TABACROHN Study . Dig Dis Week 2012 : San Diego CA, USA , 2012
    • (2012) Dig Dis Week
    • Nunes, T.1    Etchevers, M.J.2    Merino, O.3
  • 11
    • 84868514758 scopus 로고    scopus 로고
    • Infl ammatory bowel disease: A canadian burden of illness review
    • Rocchi A , Benchimol EI , Bernstein CN et al. Infl ammatory bowel disease: A Canadian burden of illness review . Can J Gastroenterol 2012 ; 26 : 811-7
    • (2012) Can J Gastroenterol , vol.26 , pp. 811-817
    • Rocchi, A.1    Benchimol, E.I.2    Bernstein, C.N.3
  • 12
    • 33750296341 scopus 로고    scopus 로고
    • Canadian Agency for Drugs and Technologies in Health 3rd Edition] Accessed 29 January 2014
    • Canadian Agency for Drugs and Technologies in Health . Guidelines for the economic evaluation of health technologies: Canada [3rd Edition]. 2006 http://www.cadth.ca/media/pdf/186-EconomicGuidelines-e.pdf. Accessed 29 January 2014
    • (2006) Guidelines for the Economic Evaluation of Health Technologies: Canada
  • 13
    • 85016499545 scopus 로고    scopus 로고
    • Individual behavioural counselling for smoking cessation
    • Lancaster T , Stead LF . Individual behavioural counselling for smoking cessation . Cochrane Database Syst Rev 2005 ; 2 : CD001292
    • (2005) Cochrane Database Syst Rev , vol.2 , pp. CD001292
    • Lancaster, T.1    Stead, L.F.2
  • 15
    • 0034566121 scopus 로고    scopus 로고
    • Nicotine replacement therapy for smoking cessation
    • Stead LF , Perera R , Bullen C et al. Nicotine replacement therapy for smoking cessation . Cochrane Database Syst Rev 2012 ; 11 : CD000146
    • (2012) Cochrane Database Syst Rev , vol.11 , pp. CD000146
    • Stead, L.F.1    Perera, R.2    Bullen, C.3
  • 16
    • 84965099454 scopus 로고    scopus 로고
    • Nicotine receptor partial agonists for smoking cessation
    • Cahill K , Stead LF , Lancaster T . Nicotine receptor partial agonists for smoking cessation . Cochrane Database Syst Rev 2012 ; 4 : CD006103
    • (2012) Cochrane Database Syst Rev , vol.4 , pp. CD006103
    • Cahill, K.1    Stead, L.F.2    Lancaster, T.3
  • 17
    • 10744224387 scopus 로고    scopus 로고
    • Comparison of scheduled and episodic treatment strategies of infl iximab in crohn's disease
    • Rutgeerts P , Feagan BG , Lichtenstein GR et al. Comparison of scheduled and episodic treatment strategies of infl iximab in Crohn's disease . Gastroenterology 2004 ; 126 : 402-13
    • (2004) Gastroenterology , vol.126 , pp. 402-413
    • Rutgeerts, P.1    Feagan, B.G.2    Lichtenstein, G.R.3
  • 18
    • 33846242958 scopus 로고    scopus 로고
    • Adalimumab for maintenance of clinical response and remission in patients with crohn's disease: The charm trial
    • Colombel JF , Sandborn WJ , Rutgeerts P et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial . Gastroenterology 2007 ; 132 : 52-65
    • (2007) Gastroenterology , vol.132 , pp. 52-65
    • Colombel, J.F.1    Sandborn, W.J.2    Rutgeerts, P.3
  • 19
    • 62049083383 scopus 로고    scopus 로고
    • Loss of response and requirement of infl iximab dose intensifi cation in crohn's disease: A review
    • Gisbert JP , Panes J . Loss of response and requirement of infl iximab dose intensifi cation in Crohn's disease: A review . Am J Gastroenterol 2009 ; 104 : 760-7
    • (2009) Am J Gastroenterol , vol.104 , pp. 760-767
    • Gisbert, J.P.1    Panes, J.2
  • 20
    • 79953786419 scopus 로고    scopus 로고
    • Loss of response and need for adalimumab dose intensifi cation in crohn's disease: A systematic review
    • Billioud V , Sandborn WJ , Peyrin-Biroulet L . Loss of response and need for adalimumab dose intensifi cation in Crohn's disease: A systematic review. Am J Gastroenterol 2011 ; 106 : 674-84
    • (2011) Am J Gastroenterol , vol.106 , pp. 674-684
    • Billioud, V.1    Sandborn, W.J.2    Peyrin-Biroulet, L.3
  • 21
    • 84924453263 scopus 로고    scopus 로고
    • Statistics Canada Accessed 10 June 2012
    • Statistics Canada . Age-Standardized mortality rates by selected causes, by sex. 2009 http://www.statcan.gc.ca/tables-Tableaux/sum-som/l01/cst01/health30a-eng.htm . Accessed 10 June 2012
    • (2009) Age-Standardized Mortality Rates by Selected Causes, by Sex
  • 22
    • 73949147970 scopus 로고    scopus 로고
    • Overall and cause-specifi c mortality in crohn's disease: A meta-analysis of population-based studies
    • Duricova D , Pedersen N , Elkjaer M et al. Overall and cause-specifi c mortality in Crohn's disease: A meta-analysis of population-based studies. Infl amm Bowel Dis 2010 ; 16 : 347-53
    • (2010) Infl Amm Bowel Dis , vol.16 , pp. 347-353
    • Duricova, D.1    Pedersen, N.2    Elkjaer, M.3
  • 23
    • 63349111119 scopus 로고    scopus 로고
    • Does smoking reduce infl iximab's eff ectiveness against Crohn's disease?
    • Narula N , Fedorak RN . Does smoking reduce infl iximab's eff ectiveness against Crohn's disease? Can J Gastroenterol 2009 ; 23 : 121-5
    • (2009) Can J Gastroenterol , vol.23 , pp. 121-125
    • Narula, N.1    Fedorak, R.N.2
  • 24
    • 71949105445 scopus 로고    scopus 로고
    • Systematic review: The short-Term and long-Term effi cacy of adalimumab following discontinuation of infl iximab
    • Ma C , Panaccione R , Heitman SJ et al. Systematic review: The short-Term and long-Term effi cacy of adalimumab following discontinuation of infl iximab . Aliment Pharmacol Ther 2009 ; 30 : 977-86
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 977-986
    • Ma, C.1    Panaccione, R.2    Heitman, S.J.3
  • 25
    • 79751472562 scopus 로고    scopus 로고
    • The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: When to start, when to stop which drug to choose, and how to predict response?
    • quiz 213
    • D'Haens GR , Panaccione R , Higgins PD et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: When to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol 2011 ; 106 : 199-212 , quiz 213
    • (2011) Am J Gastroenterol , vol.106 , pp. 199-212
    • D'Haens, G.R.1    Panaccione, R.2    Higgins, P.D.3
  • 26
    • 84924515896 scopus 로고    scopus 로고
    • Alberta Blue Cross Accessed 19 February 2014
    • Alberta Blue Cross. Alberta Blue Cross Interactive Drug Benefi t List. 2014 https://idbl.ab.bluecross.ca/idbl/load.do . Accessed 19 February 2014
    • (2014) Alberta Blue Cross Interactive Drug Benefit List
  • 27
    • 84858752735 scopus 로고    scopus 로고
    • Cost per treated patient for etanercept, adalimumab, and infl iximab across adult indications: A claims analysis
    • Bonafede MM , Gandra SR , Watson C et al. Cost per treated patient for etanercept, adalimumab, and infl iximab across adult indications: A claims analysis . Adv Ther 2012 ; 29 : 234-48
    • (2012) Adv Ther , vol.29 , pp. 234-248
    • Bonafede, M.M.1    Gandra, S.R.2    Watson, C.3
  • 28
    • 84924452642 scopus 로고    scopus 로고
    • Bureau of Labor Statistics Accessed 24 February 2014
    • Bureau of Labor Statistics . Consumer Price Index (United States of America). 2014 http://www.bls.gov/cpi/ . Accessed 24 February 2014
    • (2014) Consumer Price Index (United States of America
  • 29
    • 0003617159 scopus 로고    scopus 로고
    • Statistics Canada Accessed 19 February 2014
    • Statistics Canada . Consumer Price Index. 2014 http://www.statcan.gc.ca/tables-Tableaux/sum-som/l01/cst01/econ09a-eng.htm . Accessed 19 February 2014
    • (2014) Consumer Price Index
  • 30
    • 0033967019 scopus 로고    scopus 로고
    • The cost of hospitalization in crohn's disease
    • Cohen RD , Larson LR , Roth JM et al. The cost of hospitalization in Crohn's disease . Am J Gastroenterol 2000 ; 95 : 524-30
    • (2000) Am J Gastroenterol , vol.95 , pp. 524-530
    • Cohen, R.D.1    Larson, L.R.2    Roth, J.M.3
  • 31
    • 84863983658 scopus 로고    scopus 로고
    • Direct medical cost of managing ibd patients: A canadian population-based study
    • Bernstein CN , Longobardi T , Finlayson G et al. Direct medical cost of managing IBD patients: A Canadian population-based study . Infl amm Bowel Dise 2011 ; 18 : 1498-508
    • (2011) Infl Amm Bowel Dise , vol.18 , pp. 1498-1508
    • Bernstein, C.N.1    Longobardi, T.2    Finlayson, G.3
  • 32
    • 0001051932 scopus 로고    scopus 로고
    • An evaluation of utility measurement in crohn's disease
    • Gregor JC , McDonald JWD , Klar N et al. An evaluation of utility measurement in Crohn's disease . Infl amm Bowel Dis 1997 ; 3 : 265-76
    • (1997) Infl Amm Bowel Dis , vol.3 , pp. 265-276
    • Gregor, J.C.1    McDonald, J.W.D.2    Klar, N.3
  • 33
    • 84901508464 scopus 로고    scopus 로고
    • Environmental factors in a population-based inception cohort of infl ammatory bowel disease patients in europe-an ecco-epicom study
    • Burisch J , Pedersen N , Cukovic-Cavka S et al. Environmental factors in a population-based inception cohort of infl ammatory bowel disease patients in Europe-An ECCO-EpiCom study . J Crohns Colitis 2013 ; 8 : 607-16
    • (2013) J Crohns Colitis , vol.8 , pp. 607-616
    • Burisch, J.1    Pedersen, N.2    Cukovic-Cavka, S.3
  • 34
    • 33947546191 scopus 로고    scopus 로고
    • Update on the incidence and prevalence of crohn's disease and ulcerative colitis in olmsted county, minnesota 1940-2000
    • Loft us CG , Loft us EV Jr. , Harmsen WS et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000 . Infl amm Bowel Dis 2007 ; 13 : 254-61
    • (2007) Infl Amm Bowel Dis , vol.13 , pp. 254-261
    • Loftus, C.G.1    Loftus, E.V.2    Harmsen, W.S.3
  • 35
    • 0005536502 scopus 로고    scopus 로고
    • U.S. and World Population Clock Accessed 8 December 2013
    • United States Census Bureau. U.S. and World Population Clock . http://www.census.gov/popclock/ . Accessed 8 December 2013
    • United States Census Bureau
  • 36
    • 84902659142 scopus 로고    scopus 로고
    • Defining quality indicators for bestpractice management of infl ammatory bowel disease in canada
    • Nguyen GC , Devlin SM , Afi f W et al. Defi ning quality indicators for bestpractice management of infl ammatory bowel disease in Canada . Can J Gastroenterol Hepatol 2014 ; 28 : 275-85
    • (2014) Can J Gastroenterol Hepatol , vol.28 , pp. 275-285
    • Nguyen, G.C.1    Devlin, S.M.2    Afif, W.3
  • 37
    • 84864053696 scopus 로고    scopus 로고
    • Assessment of variables associated with smoking cessation in crohn's disease
    • Leung Y , Kaplan GG , Rioux KP et al. Assessment of variables associated with smoking cessation in Crohn's disease . Dig Dis Sci 2012 ; 57 : 1026-32
    • (2012) Dig Dis Sci , vol.57 , pp. 1026-1032
    • Leung, Y.1    Kaplan, G.G.2    Rioux, K.P.3
  • 38
    • 84884187859 scopus 로고    scopus 로고
    • Eff ects of varenicline on smoking cessation in adults with stably treated current or past major depression: A randomized trial
    • Anthenelli RM , Morris C , Ramey TS et al. Eff ects of varenicline on smoking cessation in adults with stably treated current or past major depression: A randomized trial . Ann Intern Med 2013 ; 159 : 390-400
    • (2013) Ann Intern Med , vol.159 , pp. 390-400
    • Anthenelli, R.M.1    Morris, C.2    Ramey, T.S.3
  • 39
    • 84891791619 scopus 로고    scopus 로고
    • Pharmacological interventions for smoking cessation: An overview and network meta-analysis
    • Cahill K , Stevens S , Perera R et al. Pharmacological interventions for smoking cessation: An overview and network meta-analysis . Cochrane Database Syst Rev 2013 ; 5 : CD009329
    • (2013) Cochrane Database Syst Rev , vol.5 , pp. CD009329
    • Cahill, K.1    Stevens, S.2    Perera, R.3
  • 40
    • 84889028067 scopus 로고    scopus 로고
    • Varenicline, smoking cessation, and neuropsychiatric adverse events
    • Gibbons RD , Mann JJ . Varenicline, smoking cessation, and neuropsychiatric adverse events . Am J Psychiatry 2013 ; 170 : 1460-7
    • (2013) Am J Psychiatry , vol.170 , pp. 1460-1467
    • Gibbons, R.D.1    Mann, J.J.2
  • 41
    • 84924445343 scopus 로고    scopus 로고
    • U.S. Food Drug Administration Accessed 24 May 2014
    • U.S. Food and Drug Administration . Postmarket Drug Safety Information for Patients and Providers (Varenicline). 2014 http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsand Providers/ucm124818.htm . Accessed 24 May 2014
    • (2014) Postmarket Drug Safety Information for Patients and Providers (Varenicline
  • 42
    • 84924512057 scopus 로고    scopus 로고
    • Alberta Health Services Accessed 19 February 2014
    • Alberta Health Services . Alberta Health Services Job Board. 2014 http://www.albertahealthservices.ca/careers/ . Accessed 19 February 2014
    • (2014) Alberta Health Services Job Board
  • 43
    • 84924483159 scopus 로고    scopus 로고
    • Addiction Centre Accessed 6 June 2012
    • Alberta Health Services . Addiction Centre. 2012 www.addictioncentre.ca. Accessed 6 June 2012
    • (2012) Alberta Health Services


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.